Home
>
National Drug Code (NDC)
>
DepoCyt
DepoCyt - 57665-331-01 - (Cytarabine)
Drug Information of DepoCyt
| Product NDC: | 57665-331 |
| Proprietary Name: | DepoCyt |
| Non Proprietary Name: | Cytarabine |
| Active Ingredient(s): | 50 mg/5mL & nbsp; Cytarabine |
| Administration Route(s): | INTRATHECAL |
| Dosage Form(s): | INJECTION, LIPID COMPLEX |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DepoCyt
| Product NDC: | 57665-331 |
| Labeler Name: | Sigma-Tau Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021041 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101022 |
Package Information of DepoCyt
| Package NDC: | 57665-331-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (57665-331-01) > 5 mL in 1 VIAL, SINGLE-USE |
NDC Information of DepoCyt
| NDC Code | 57665-331-01 |
| Proprietary Name | DepoCyt |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (57665-331-01) > 5 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 57665-331 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cytarabine |
| Dosage Form Name | INJECTION, LIPID COMPLEX |
| Route Name | INTRATHECAL |
| Start Marketing Date | 20101022 |
| Marketing Category Name | NDA |
| Labeler Name | Sigma-Tau Pharmaceuticals, Inc. |
| Substance Name | CYTARABINE |
| Strength Number | 50 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
